Professional Documents
Culture Documents
Prescotts Microbiology Willey 9th Edition Test Bank Full Download
Prescotts Microbiology Willey 9th Edition Test Bank Full Download
Chapter 09
Antimicrobial Chemotherapy
9-1
© 2014 by McGraw-Hill Education. This is proprietary material solely for authorized instructor use. Not authorized for sale or distribution in
any manner. This document may not be copied, scanned, duplicated, forwarded, distributed, or posted on a website, in whole or part
Chapter 09 - Antimicrobial Chemotherapy
4. Chemotherapeutic agents that are natural products of microorganisms are most specifically
referred to as __________.
A. antimicrobial agents
B. synthetic drugs
C. antibiotics
D. semisynthetic drugs
9-2
© 2014 by McGraw-Hill Education. This is proprietary material solely for authorized instructor use. Not authorized for sale or distribution in
any manner. This document may not be copied, scanned, duplicated, forwarded, distributed, or posted on a website, in whole or part
Chapter 09 - Antimicrobial Chemotherapy
6. __________ __________ are activities of a chemotherapeutic agent that damage the host
either by inhibiting the same process in the host as in the target cell or by damaging other
processes.
Side effects
9-3
© 2014 by McGraw-Hill Education. This is proprietary material solely for authorized instructor use. Not authorized for sale or distribution in
any manner. This document may not be copied, scanned, duplicated, forwarded, distributed, or posted on a website, in whole or part
Chapter 09 - Antimicrobial Chemotherapy
7. The minimum lethal concentration (MLC) is the lowest concentration of drug from which
organisms fail to recover when removed from the drug.
TRUE
8. Agents that are static and, therefore, do not kill infecting microorganisms are not useful as
chemotherapeutic agents.
FALSE
9-4
© 2014 by McGraw-Hill Education. This is proprietary material solely for authorized instructor use. Not authorized for sale or distribution in
any manner. This document may not be copied, scanned, duplicated, forwarded, distributed, or posted on a website, in whole or part
Chapter 09 - Antimicrobial Chemotherapy
9. A drug that disrupts a microbial function not found in animal cells usually has a higher
therapeutic index.
TRUE
10. The drug level required for the clinical treatment of a particular infection is called the
A. therapeutic dose.
B. toxic dose.
C. therapeutic index.
D. minimal inhibitory concentration.
9-5
© 2014 by McGraw-Hill Education. This is proprietary material solely for authorized instructor use. Not authorized for sale or distribution in
any manner. This document may not be copied, scanned, duplicated, forwarded, distributed, or posted on a website, in whole or part
Chapter 09 - Antimicrobial Chemotherapy
ASM Objective: 02.01 Bacteria have unique cell structures that can be targets for antibiotics,
immunity and phage infection.
ASM Topic: Module 06 Impact of Microorganisms
Blooms Level: 2. Understand
Learning Outcome: 09.04.01 Compare antibacterial drug mechanisms of action
Section: 09.04
Topic: Antimicrobial Medications
12. Which of the following is likely to have the most toxic side effects to humans?
A. Inhibitors of cell wall synthesis.
B. Inhibitors of protein synthesis.
C. Disrupters of cell membrane structure.
D. Inhibitors of DNA synthesis.
ASM Objective: 02.01 Bacteria have unique cell structures that can be targets for antibiotics,
immunity and phage infection.
ASM Topic: Module 06 Impact of Microorganisms
Blooms Level: 3. Apply
Learning Outcome: 09.04.01 Compare antibacterial drug mechanisms of action
Section: 09.04
9-6
© 2014 by McGraw-Hill Education. This is proprietary material solely for authorized instructor use. Not authorized for sale or distribution in
any manner. This document may not be copied, scanned, duplicated, forwarded, distributed, or posted on a website, in whole or part
Chapter 09 - Antimicrobial Chemotherapy
ASM Objective: 02.01 Bacteria have unique cell structures that can be targets for antibiotics,
immunity and phage infection.
Blooms Level: 2. Understand
Learning Outcome: 09.04.03 Explain the relative effectiveness of various antibacterial agents
based on drug target
Section: 09.04
Topic: Antimicrobial Medications
14. Consider an antibacterial drug. In which of the following cases would the action of the
drug be considered primarily bacteriostatic?
A. The minimal lethal concentration (MLC) is equal to the minimal inhibitory concentration
(MIC).
B. The MLC is lower than the MIC.
C. The MLC is 2-4 times higher than the MIC.
D. The MLC is 10-20 times higher than the MIC.
ASM Objective: 02.01 Bacteria have unique cell structures that can be targets for antibiotics,
immunity and phage infection.
ASM Topic: Module 06 Impact of Microorganisms
Blooms Level: 2. Understand
Learning Outcome: 09.03.01 Explain how to determine the level of antibacterial drug activity
using the dilution susceptibility test, the disk diffusion test, and the Etest®
Section: 09.03
Topic: Antimicrobial Medications
9-7
© 2014 by McGraw-Hill Education. This is proprietary material solely for authorized instructor use. Not authorized for sale or distribution in
any manner. This document may not be copied, scanned, duplicated, forwarded, distributed, or posted on a website, in whole or part
Chapter 09 - Antimicrobial Chemotherapy
ASM Objective: 02.01 Bacteria have unique cell structures that can be targets for antibiotics,
immunity and phage infection.
ASM Topic: Module 06 Impact of Microorganisms
Blooms Level: 1. Remember
Learning Outcome: 09.01.02 Propose natural sources of new antimicrobial agents
Section: 09.04
Topic: Antimicrobial Medications
16. Chemotherapeutic agents that are artificially produced are most specifically referred to as
__________.
A. antimicrobial agents
B. synthetic drugs
C. antibiotics
D. semisynthetic drugs
ASM Objective: 02.01 Bacteria have unique cell structures that can be targets for antibiotics,
immunity and phage infection.
ASM Topic: Module 06 Impact of Microorganisms
Blooms Level: 1. Remember
Learning Outcome: 09.01.02 Propose natural sources of new antimicrobial agents
Section: 09.04
Topic: Antimicrobial Medications
9-8
© 2014 by McGraw-Hill Education. This is proprietary material solely for authorized instructor use. Not authorized for sale or distribution in
any manner. This document may not be copied, scanned, duplicated, forwarded, distributed, or posted on a website, in whole or part
Chapter 09 - Antimicrobial Chemotherapy
ASM Objective: 02.01 Bacteria have unique cell structures that can be targets for antibiotics,
immunity and phage infection.
Blooms Level: 2. Understand
Learning Outcome: 09.02.02 Correlate lack of microbial growth with selective toxicity
Section: 09.02
Topic: Antimicrobial Medications
ASM Objective: 02.01 Bacteria have unique cell structures that can be targets for antibiotics,
immunity and phage infection.
ASM Topic: Module 06 Impact of Microorganisms
Learning Outcome: 09.03.01 Explain how to determine the level of antibacterial drug activity
using the dilution susceptibility test, the disk diffusion test, and the Etest®
Section: 09.03
Topic: Antimicrobial Medications
9-9
© 2014 by McGraw-Hill Education. This is proprietary material solely for authorized instructor use. Not authorized for sale or distribution in
any manner. This document may not be copied, scanned, duplicated, forwarded, distributed, or posted on a website, in whole or part
Chapter 09 - Antimicrobial Chemotherapy
ASM Objective: 02.01 Bacteria have unique cell structures that can be targets for antibiotics,
immunity and phage infection.
ASM Topic: Module 06 Impact of Microorganisms
Learning Outcome: 09.03.01 Explain how to determine the level of antibacterial drug activity
using the dilution susceptibility test, the disk diffusion test, and the Etest®
Section: 09.03
Topic: Antimicrobial Medications
21. When a chemotherapeutic agent is effective against many different pathogens, it is said to
be a __________ antibiotic.
broad-spectrum
ASM Objective: 02.01 Bacteria have unique cell structures that can be targets for antibiotics,
immunity and phage infection.
ASM Topic: Module 06 Impact of Microorganisms
Blooms Level: 2. Understand
Learning Outcome: 09.02.01 Explain the difference between a narrow and broad spectrum
drug
Section: 09.02
Topic: Antimicrobial Medications
9-10
© 2014 by McGraw-Hill Education. This is proprietary material solely for authorized instructor use. Not authorized for sale or distribution in
any manner. This document may not be copied, scanned, duplicated, forwarded, distributed, or posted on a website, in whole or part
Chapter 09 - Antimicrobial Chemotherapy
22. In a disk diffusion assay for drug susceptibility, a drug producing a larger clear zone is
always more effective than a drug than to one producing a smaller clear zone.
FALSE
ASM Objective: 02.01 Bacteria have unique cell structures that can be targets for antibiotics,
immunity and phage infection.
ASM Topic: Module 06 Impact of Microorganisms
Learning Outcome: 09.03.01 Explain how to determine the level of antibacterial drug activity
using the dilution susceptibility test, the disk diffusion test, and the Etest®
Section: 09.03
Topic: Antimicrobial Medications
23. Which of the following affects the size of the clear zone in a disk diffusion test of
antimicrobial susceptibility?
A. the initial concentration of the drug
B. the solubility of the drug
C. the diffusion rate of the drug
D. all of the choices
ASM Objective: 02.01 Bacteria have unique cell structures that can be targets for antibiotics,
immunity and phage infection.
ASM Topic: Module 06 Impact of Microorganisms
Learning Outcome: 09.03.01 Explain how to determine the level of antibacterial drug activity
using the dilution susceptibility test, the disk diffusion test, and the Etest®
Section: 09.03
Topic: Antimicrobial Medications
9-11
© 2014 by McGraw-Hill Education. This is proprietary material solely for authorized instructor use. Not authorized for sale or distribution in
any manner. This document may not be copied, scanned, duplicated, forwarded, distributed, or posted on a website, in whole or part
Chapter 09 - Antimicrobial Chemotherapy
ASM Objective: 02.01 Bacteria have unique cell structures that can be targets for antibiotics,
immunity and phage infection.
ASM Topic: Module 06 Impact of Microorganisms
Learning Outcome: 09.03.01 Explain how to determine the level of antibacterial drug activity
using the dilution susceptibility test, the disk diffusion test, and the Etest®
Section: 09.03
Topic: Antimicrobial Medications
25. In the broth dilution test, the highest concentration of the antibiotic resulting in no growth
after 16 to 20 hours of incubation is the MIC.
FALSE
ASM Objective: 02.01 Bacteria have unique cell structures that can be targets for antibiotics,
immunity and phage infection.
ASM Topic: Module 06 Impact of Microorganisms
Blooms Level: 2. Understand
Learning Outcome: 09.03.01 Explain how to determine the level of antibacterial drug activity
using the dilution susceptibility test, the disk diffusion test, and the Etest®
Section: 09.03
Topic: Antimicrobial Medications
9-12
© 2014 by McGraw-Hill Education. This is proprietary material solely for authorized instructor use. Not authorized for sale or distribution in
any manner. This document may not be copied, scanned, duplicated, forwarded, distributed, or posted on a website, in whole or part
Chapter 09 - Antimicrobial Chemotherapy
26. Which of the following is not true about Kirby-Bauer disk diffusion method?
A. After inoculation of bacteria, the agar surface is dried for about 5 minutes and the
appropriate antibiotic test disks are placed on it.
B. The plate is placed at 35C for 16 to 18 hours of incubation.
C. Bacteria used to swab plate should be at least a week old.
D. The diameters of the zones of inhibition are measured to the nearest millimeter.
ASM Objective: 02.01 Bacteria have unique cell structures that can be targets for antibiotics,
immunity and phage infection.
ASM Topic: Module 06 Impact of Microorganisms
Blooms Level: 2. Understand
Learning Outcome: 09.03.01 Explain how to determine the level of antibacterial drug activity
using the dilution susceptibility test, the disk diffusion test, and the Etest®
Section: 09.03
Topic: Antimicrobial Medications
ASM Objective: 02.01 Bacteria have unique cell structures that can be targets for antibiotics,
immunity and phage infection.
ASM Topic: Module 06 Impact of Microorganisms
Blooms Level: 2. Understand
Learning Outcome: 09.04.01 Compare antibacterial drug mechanisms of action
Section: 09.04
Topic: Antimicrobial Medications
9-13
© 2014 by McGraw-Hill Education. This is proprietary material solely for authorized instructor use. Not authorized for sale or distribution in
any manner. This document may not be copied, scanned, duplicated, forwarded, distributed, or posted on a website, in whole or part
Chapter 09 - Antimicrobial Chemotherapy
28. The most selective antibacterial agents are those that interfere with bacterial cell wall
synthesis. This is because
A. bacterial cell walls have a unique structure not found in eukaryotic host cells.
B. bacterial cell wall synthesis is easily inhibited whereas eukaryotic cell wall synthesis is
more resistant to the actions of the drugs.
C. eukaryotic cells do not take up the drugs.
D. eukaryotic cells inactivate the drugs before they can do any damage.
29. In addition to inhibiting the transpeptidation reaction in cell wall synthesis, penicillins
may also destroy bacteria by
A. inhibiting DNA replication.
B. stimulating proteins to form holes in the plasma membrane.
C. inhibiting protein synthesis.
D. none of the choices
ASM Objective: 02.01 Bacteria have unique cell structures that can be targets for antibiotics,
immunity and phage infection.
ASM Topic: Module 06 Impact of Microorganisms
Learning Outcome: 09.04.01 Compare antibacterial drug mechanisms of action
Section: 09.04
Topic: Antimicrobial Medications
ASM Objective: 02.01 Bacteria have unique cell structures that can be targets for antibiotics,
immunity and phage infection.
ASM Topic: Module 06 Impact of Microorganisms
Blooms Level: 2. Understand
Learning Outcome: 09.04.01 Compare antibacterial drug mechanisms of action
Section: 09.04
Topic: Antimicrobial Medications
9-14
© 2014 by McGraw-Hill Education. This is proprietary material solely for authorized instructor use. Not authorized for sale or distribution in
any manner. This document may not be copied, scanned, duplicated, forwarded, distributed, or posted on a website, in whole or part
Chapter 09 - Antimicrobial Chemotherapy
31. Sulfonamides and other drugs that inhibit folic acid synthesis have a high therapeutic
index because
A. humans do not use folic acid.
B. humans do not synthesize folic acid but obtain it in their diets.
C. humans synthesize folic acid by a process that is not sensitive to sulfonamides.
D. none of these
ASM Objective: 02.01 Bacteria have unique cell structures that can be targets for antibiotics,
immunity and phage infection.
ASM Topic: Module 06 Impact of Microorganisms
Blooms Level: 2. Understand
Learning Outcome: 09.04.01 Compare antibacterial drug mechanisms of action
Section: 09.04
Topic: Antimicrobial Medications
32. Antibiotics that are given by injection are said to have a(n) __________ route of
administration.
A. oral
B. venal
C. parenteral
D. topical
ASM Objective: 02.01 Bacteria have unique cell structures that can be targets for antibiotics,
immunity and phage infection.
ASM Topic: Module 06 Impact of Microorganisms
Learning Outcome: 09.04.03 Explain the relative effectiveness of various antibacterial agents
based on drug target
Section: 09.08
Topic: Antimicrobial Medications
9-15
© 2014 by McGraw-Hill Education. This is proprietary material solely for authorized instructor use. Not authorized for sale or distribution in
any manner. This document may not be copied, scanned, duplicated, forwarded, distributed, or posted on a website, in whole or part
Chapter 09 - Antimicrobial Chemotherapy
33. Sulfonamides inhibit the production of folic acid and, therefore, inhibit the synthesis of
__________.
A. purines and pyrimidines
B. ribose
C. aromatic amino acids
D. peptidoglycan
ASM Objective: 02.01 Bacteria have unique cell structures that can be targets for antibiotics,
immunity and phage infection.
ASM Topic: Module 06 Impact of Microorganisms
Blooms Level: 2. Understand
Learning Outcome: 09.04.01 Compare antibacterial drug mechanisms of action
Section: 09.04
Topic: Antimicrobial Medications
ASM Objective: 02.01 Bacteria have unique cell structures that can be targets for antibiotics,
immunity and phage infection.
ASM Topic: Module 06 Impact of Microorganisms
Blooms Level: 2. Understand
Learning Outcome: 09.04.01 Compare antibacterial drug mechanisms of action
Section: 09.04
Topic: Antimicrobial Medications
9-16
© 2014 by McGraw-Hill Education. This is proprietary material solely for authorized instructor use. Not authorized for sale or distribution in
any manner. This document may not be copied, scanned, duplicated, forwarded, distributed, or posted on a website, in whole or part
Chapter 09 - Antimicrobial Chemotherapy
35. Bacitracin
A. inhibits DNA replication.
B. inhibits peptidoglycan synthesis.
C. interferes with protein synthesis.
D. interferes with plasma membrane function.
ASM Objective: 02.01 Bacteria have unique cell structures that can be targets for antibiotics,
immunity and phage infection.
Blooms Level: 2. Understand
Learning Outcome: 09.04.01 Compare antibacterial drug mechanisms of action
Section: 09.04
Topic: Antimicrobial Medications
36. Vancomycin
A. inhibits the transglycosylase reaction in peptidoglycan biosynthesis.
B. interferes with the action of the lipid carrier that transports peptidoglycan precursors across
the plasma membrane.
C. inhibits the transpeptidation reaction in peptidoglycan biosynthesis.
D. blocks the addition of the pentapeptide chain during peptidoglycan biosynthesis.
ASM Objective: 02.01 Bacteria have unique cell structures that can be targets for antibiotics,
immunity and phage infection.
ASM Topic: Module 06 Impact of Microorganisms
Blooms Level: 2. Understand
Learning Outcome: 09.04.01 Compare antibacterial drug mechanisms of action
Section: 09.04
Topic: Antimicrobial Medications
9-17
© 2014 by McGraw-Hill Education. This is proprietary material solely for authorized instructor use. Not authorized for sale or distribution in
any manner. This document may not be copied, scanned, duplicated, forwarded, distributed, or posted on a website, in whole or part
Chapter 09 - Antimicrobial Chemotherapy
37. Which of the following is a useful mechanism of action for an antibacterial drug?
A. Inhibition of cell wall synthesis.
B. Inhibition of protein synthesis.
C. Interference with RNA and DNA synthesis.
D. All of the choices.
ASM Objective: 02.01 Bacteria have unique cell structures that can be targets for antibiotics,
immunity and phage infection.
ASM Topic: Module 06 Impact of Microorganisms
Learning Outcome: 09.04.01 Compare antibacterial drug mechanisms of action
Section: 09.04
Topic: Antimicrobial Medications
ASM Objective: 02.01 Bacteria have unique cell structures that can be targets for antibiotics,
immunity and phage infection.
ASM Topic: Module 06 Impact of Microorganisms
Learning Outcome: 09.04.01 Compare antibacterial drug mechanisms of action
Section: 09.04
Topic: Antimicrobial Medications
9-18
© 2014 by McGraw-Hill Education. This is proprietary material solely for authorized instructor use. Not authorized for sale or distribution in
any manner. This document may not be copied, scanned, duplicated, forwarded, distributed, or posted on a website, in whole or part
Chapter 09 - Antimicrobial Chemotherapy
39. Protein synthesis inhibitors have a low therapeutic index because they usually cannot
discriminate between prokaryotic and eukaryotic ribosomes.
FALSE
ASM Objective: 02.01 Bacteria have unique cell structures that can be targets for antibiotics,
immunity and phage infection.
ASM Topic: Module 06 Impact of Microorganisms
Blooms Level: 3. Apply
Learning Outcome: 09.04.01 Compare antibacterial drug mechanisms of action
Section: 09.04
Topic: Antimicrobial Medications
ASM Objective: 02.01 Bacteria have unique cell structures that can be targets for antibiotics,
immunity and phage infection.
ASM Topic: Module 06 Impact of Microorganisms
Blooms Level: 2. Understand
Learning Outcome: 09.04.02 Relate side effect toxicity of antibacterial drugs to mechanism of
action
Section: 09.08
Topic: Antimicrobial Medications
9-19
© 2014 by McGraw-Hill Education. This is proprietary material solely for authorized instructor use. Not authorized for sale or distribution in
any manner. This document may not be copied, scanned, duplicated, forwarded, distributed, or posted on a website, in whole or part
Chapter 09 - Antimicrobial Chemotherapy
41. A(n) __________ is a drug that blocks the function of a metabolic pathway.
antimetabolite
ASM Objective: 02.01 Bacteria have unique cell structures that can be targets for antibiotics,
immunity and phage infection.
ASM Topic: Module 03 Metabolic Pathways
Blooms Level: 2. Understand
Learning Outcome: 09.04.01 Compare antibacterial drug mechanisms of action
Section: 09.04
Topic: Antimicrobial Medications
42. Which of the following is normally treated by antifungal creams and solutions?
A. Systemic mycoses.
B. Superficial mycoses.
C. Subcutaneous mycoses.
D. Intramuscular mycoses.
ASM Objective: 02.01 Bacteria have unique cell structures that can be targets for antibiotics,
immunity and phage infection.
ASM Topic: Module 05 Systems
Blooms Level: 2. Understand
Learning Outcome: 09.05.01 Compare antifungal drug mechanisms of action
Section: 09.05
Topic: Antimicrobial Medications
9-20
© 2014 by McGraw-Hill Education. This is proprietary material solely for authorized instructor use. Not authorized for sale or distribution in
any manner. This document may not be copied, scanned, duplicated, forwarded, distributed, or posted on a website, in whole or part
Chapter 09 - Antimicrobial Chemotherapy
43. The treatment for pneumonia caused by Pneumocystis jiroveci in AIDS patients is
A. atovaquone
B. miconazole
C. pentamidine
D. either atovaquone or pentamidine
ASM Objective: 05.04 Microorganisms, cellular and viral, interact with both human and non-
human hosts in beneficial, neutral or detrimental ways.
Blooms Level: 2. Understand
Learning Outcome: 09.05.01 Compare antifungal drug mechanisms of action
Section: 09.05
Topic: Antimicrobial Medications
ASM Objective: 05.04 Microorganisms, cellular and viral, interact with both human and non-
human hosts in beneficial, neutral or detrimental ways.
ASM Topic: Module 05 Systems
Blooms Level: 2. Understand
Learning Outcome: 09.05.02 Explain why there are far fewer antifungal agents than there are
antibacterial agents
Section: 09.05
Topic: Antimicrobial Medications
9-21
© 2014 by McGraw-Hill Education. This is proprietary material solely for authorized instructor use. Not authorized for sale or distribution in
any manner. This document may not be copied, scanned, duplicated, forwarded, distributed, or posted on a website, in whole or part
Chapter 09 - Antimicrobial Chemotherapy
45. Treatment of fungal infections is more difficult than treatment of bacterial infections
because the greater metabolic similarity between the fungi and their hosts limits the ability of
a drug to have a selective toxicity.
TRUE
ASM Objective: 05.04 Microorganisms, cellular and viral, interact with both human and non-
human hosts in beneficial, neutral or detrimental ways.
ASM Topic: Module 05 Systems
Learning Outcome: 09.05.02 Explain why there are far fewer antifungal agents than there are
antibacterial agents
Section: 09.05
Topic: Antimicrobial Medications
ASM Objective: 05.04 Microorganisms, cellular and viral, interact with both human and non-
human hosts in beneficial, neutral or detrimental ways.
ASM Topic: Module 05 Systems
Blooms Level: 2. Understand
Learning Outcome: 09.06.01 Compare antiviral drug mechanisms of action
Section: 09.06
Topic: Antimicrobial Medications
9-22
© 2014 by McGraw-Hill Education. This is proprietary material solely for authorized instructor use. Not authorized for sale or distribution in
any manner. This document may not be copied, scanned, duplicated, forwarded, distributed, or posted on a website, in whole or part
Chapter 09 - Antimicrobial Chemotherapy
ASM Objective: 05.04 Microorganisms, cellular and viral, interact with both human and non-
human hosts in beneficial, neutral or detrimental ways.
ASM Topic: Module 05 Systems
Blooms Level: 2. Understand
Learning Outcome: 09.06.01 Compare antiviral drug mechanisms of action
Section: 09.05
Topic: Antimicrobial Medications
48. Which of the following is the major reason why it has been difficult to treat viral
infections with chemotherapeutic agents?
A. Viral metabolism resembles that of their hosts so there is no selective point of attack.
B. Viruses use the metabolic machinery of their hosts, which limits many of the potential
points of attack.
C. Viruses have no metabolism and therefore offer no selective point of attack.
D. Actually, viruses are not difficult to treat with chemotherapeutic agents.
ASM Objective: 05.04 Microorganisms, cellular and viral, interact with both human and non-
human hosts in beneficial, neutral or detrimental ways.
ASM Topic: Module 02 Structure and Function
Blooms Level: 3. Apply
Learning Outcome: 09.06.03 Explain why there are far fewer antiviral agents than there are
antibacterial agents
Section: 09.05
9-23
© 2014 by McGraw-Hill Education. This is proprietary material solely for authorized instructor use. Not authorized for sale or distribution in
any manner. This document may not be copied, scanned, duplicated, forwarded, distributed, or posted on a website, in whole or part
Chapter 09 - Antimicrobial Chemotherapy
49. ________ and ________ can be used to prevent influenza A infections, reducing the
incidence of influenza by 50 to 70% in an exposed population.
Amantadine, rimantadine
ASM Objective: 05.04 Microorganisms, cellular and viral, interact with both human and non-
human hosts in beneficial, neutral or detrimental ways.
ASM Topic: Module 01 Evolution
Blooms Level: 3. Apply
Learning Outcome: 09.06.03 Explain why there are far fewer antiviral agents than there are
antibacterial agents
Section: 09.08
Topic: Antimicrobial Medications
50. All of the following are reverse transcriptase inhibitors used to treat HIV infection except
A. azidothymidine.
B. zalcitabine.
C. lamivudine.
D. didanosine.
E. acyclovir.
ASM Objective: 05.04 Microorganisms, cellular and viral, interact with both human and non-
human hosts in beneficial, neutral or detrimental ways.
Blooms Level: 1. Remember
Learning Outcome: 09.06.02 Provide a rationale for combination drug therapy, using an
anti-HIV model
Section: 09.06
Topic: Antimicrobial Medications
9-24
© 2014 by McGraw-Hill Education. This is proprietary material solely for authorized instructor use. Not authorized for sale or distribution in
any manner. This document may not be copied, scanned, duplicated, forwarded, distributed, or posted on a website, in whole or part
Chapter 09 - Antimicrobial Chemotherapy
51. The antiviral drugs currently approved for use in HIV disease include
A. nucleoside reverse transcriptase inhibitors.
B. nonnucleoside reverse transcriptase inhibitors.
C. protease inhibitors.
D. fusion inhibitors.
E. all of the choices
ASM Objective: 05.04 Microorganisms, cellular and viral, interact with both human and non-
human hosts in beneficial, neutral or detrimental ways.
ASM Topic: Module 02 Structure and Function
Blooms Level: 2. Understand
Learning Outcome: 09.06.02 Provide a rationale for combination drug therapy, using an
anti-HIV model
Section: 09.06
Topic: Antimicrobial Medications
ASM Objective: 05.04 Microorganisms, cellular and viral, interact with both human and non-
human hosts in beneficial, neutral or detrimental ways.
ASM Topic: Module 06 Impact of Microorganisms
Blooms Level: 2. Understand
Learning Outcome: 09.07.01 Compare the mechanisms of action of antiprotozoan drugs
Section: 09.07
Topic: Antimicrobial Medications
9-25
© 2014 by McGraw-Hill Education. This is proprietary material solely for authorized instructor use. Not authorized for sale or distribution in
any manner. This document may not be copied, scanned, duplicated, forwarded, distributed, or posted on a website, in whole or part
Chapter 09 - Antimicrobial Chemotherapy
ASM Objective: 05.04 Microorganisms, cellular and viral, interact with both human and non-
human hosts in beneficial, neutral or detrimental ways.
ASM Topic: Module 06 Impact of Microorganisms
Blooms Level: 2. Understand
Learning Outcome: 09.07.01 Compare the mechanisms of action of antiprotozoan drugs
Section: 09.07
Topic: Antimicrobial Medications
54. The antimicrobial action of artemisinin is not well understood but this chemical appears
to
A. swell the Plasmodium falciparum food vacuoles.
B. form reactive oxygen intermediates inside Plasmodium-infected red blood cells.
C. inhibit heme polymerase, an enzyme that converts toxic heme into nontoxic hemazoin.
D. raise the internal pH, clump the plasmodial pigment, and intercalate into plasmodial DNA.
ASM Objective: 05.04 Microorganisms, cellular and viral, interact with both human and non-
human hosts in beneficial, neutral or detrimental ways.
ASM Topic: Module 03 Metabolic Pathways
Blooms Level: 2. Understand
Learning Outcome: 09.07.01 Compare the mechanisms of action of antiprotozoan drugs
Section: 09.07
Topic: Antimicrobial Medications
9-26
© 2014 by McGraw-Hill Education. This is proprietary material solely for authorized instructor use. Not authorized for sale or distribution in
any manner. This document may not be copied, scanned, duplicated, forwarded, distributed, or posted on a website, in whole or part
Chapter 09 - Antimicrobial Chemotherapy
55. Most of the drugs used to treat protozoan infection have insignificant side effects; because
protozoa are prokaryotes, the potential for drug action on host cells and tissues is less than it
is when targeting bacteria.
FALSE
ASM Objective: 05.04 Microorganisms, cellular and viral, interact with both human and non-
human hosts in beneficial, neutral or detrimental ways.
ASM Topic: Module 02 Structure and Function
Blooms Level: 3. Apply
Learning Outcome: 09.07.03 Explain why there are far fewer antiprotozoan agents than there
are antibacterial agents
Section: 09.07
Topic: Antimicrobial Medications
ASM Objective: 05.04 Microorganisms, cellular and viral, interact with both human and non-
human hosts in beneficial, neutral or detrimental ways.
ASM Topic: Module 05 Systems
Blooms Level: 2. Understand
Learning Outcome: 09.07.01 Compare the mechanisms of action of antiprotozoan drugs
Section: 09.07
Topic: Antimicrobial Medications
9-27
© 2014 by McGraw-Hill Education. This is proprietary material solely for authorized instructor use. Not authorized for sale or distribution in
any manner. This document may not be copied, scanned, duplicated, forwarded, distributed, or posted on a website, in whole or part
Chapter 09 - Antimicrobial Chemotherapy
57. Bacteria in biofilms or abscesses may be replicating very slowly and are therefore
resistant to chemotherapy because many agents affect pathogens only if they are actively
growing and dividing.
TRUE
ASM Objective: 05.04 Microorganisms, cellular and viral, interact with both human and non-
human hosts in beneficial, neutral or detrimental ways.
ASM Topic: Module 02 Structure and Function
Blooms Level: 3. Apply
Learning Outcome: 09.08.02 Correlate the sensitivity of a microorganism to an antimicrobial
agent with microbial growth in the presence of that agent
Section: 09.08
Topic: Antimicrobial Medications
58. The chemotherapeutic agent must reach levels in the body that are ________ the
pathogen’s MIC value if it is going to be effective.
A. greater than
B. equal to
C. less than
D. none of the choices
ASM Objective: 05.04 Microorganisms, cellular and viral, interact with both human and non-
human hosts in beneficial, neutral or detrimental ways.
ASM Topic: Module 06 Impact of Microorganisms
Blooms Level: 3. Apply
Learning Outcome: 09.08.02 Correlate the sensitivity of a microorganism to an antimicrobial
agent with microbial growth in the presence of that agent
Section: 09.08
Topic: Antimicrobial Medications
9-28
© 2014 by McGraw-Hill Education. This is proprietary material solely for authorized instructor use. Not authorized for sale or distribution in
any manner. This document may not be copied, scanned, duplicated, forwarded, distributed, or posted on a website, in whole or part
Chapter 09 - Antimicrobial Chemotherapy
59. The concentration of an antimicrobial drug that is reached in the body will depend on
A. the amount of drug administered.
B. the route of administration and speed of uptake.
C. the rate at which the drug is cleared or eliminated from the body.
D. all of the choices
ASM Objective: 05.04 Microorganisms, cellular and viral, interact with both human and non-
human hosts in beneficial, neutral or detrimental ways.
ASM Topic: Module 05 Systems
Blooms Level: 2. Understand
Learning Outcome: 09.08.01 Predict the effects of (1) delivery route, (2) metabolism, and (3)
local concentration on the effectiveness of an antimicrobial drug
Section: 09.08
Topic: Antimicrobial Medications
60. Penicillin is frequently injected but not normally given orally because it is rapidly
degraded in the stomach.
TRUE
ASM Objective: 05.04 Microorganisms, cellular and viral, interact with both human and non-
human hosts in beneficial, neutral or detrimental ways.
ASM Topic: Module 02 Structure and Function
Blooms Level: 2. Understand
Learning Outcome: 09.08.02 Correlate the sensitivity of a microorganism to an antimicrobial
agent with microbial growth in the presence of that agent
Section: 09.08
Topic: Antimicrobial Medications
9-29
© 2014 by McGraw-Hill Education. This is proprietary material solely for authorized instructor use. Not authorized for sale or distribution in
any manner. This document may not be copied, scanned, duplicated, forwarded, distributed, or posted on a website, in whole or part
Chapter 09 - Antimicrobial Chemotherapy
ASM Objective: 05.04 Microorganisms, cellular and viral, interact with both human and non-
human hosts in beneficial, neutral or detrimental ways.
ASM Topic: Module 01 Evolution
Blooms Level: 2. Understand
Learning Outcome: 09.08.03 Identify practices that lead to antimicrobial drug resistance and
suggest countermeasures
Section: 09.08
Topic: Antimicrobial Medications
62. One way in which organisms may exhibit resistance to a drug is the ability to pump the
drug out of the cell immediately after it has entered.
TRUE
ASM Objective: 05.04 Microorganisms, cellular and viral, interact with both human and non-
human hosts in beneficial, neutral or detrimental ways.
ASM Topic: Module 01 Evolution
Blooms Level: 2. Understand
Learning Outcome: 09.08.03 Identify practices that lead to antimicrobial drug resistance and
suggest countermeasures
Section: 09.08
Topic: Antimicrobial Medications
9-30
© 2014 by McGraw-Hill Education. This is proprietary material solely for authorized instructor use. Not authorized for sale or distribution in
any manner. This document may not be copied, scanned, duplicated, forwarded, distributed, or posted on a website, in whole or part
Chapter 09 - Antimicrobial Chemotherapy
63. The effects of most antimicrobial drugs are greater if the microorganisms are actively
growing.
TRUE
ASM Objective: 05.04 Microorganisms, cellular and viral, interact with both human and non-
human hosts in beneficial, neutral or detrimental ways.
ASM Topic: Module 03 Metabolic Pathways
Blooms Level: 2. Understand
Learning Outcome: 09.08.01 Predict the effects of (1) delivery route, (2) metabolism, and (3)
local concentration on the effectiveness of an antimicrobial drug
Section: 09.08
Topic: Antimicrobial Medications
64. One way that the development of drug resistance in viruses has been reduced has been by
the use of a cocktail of several drugs at high doses.
TRUE
ASM Objective: 05.04 Microorganisms, cellular and viral, interact with both human and non-
human hosts in beneficial, neutral or detrimental ways.
ASM Topic: Module 01 Evolution
Blooms Level: 2. Understand
Learning Outcome: 09.08.03 Identify practices that lead to antimicrobial drug resistance and
suggest countermeasures
Section: 09.08
Topic: Antimicrobial Medications
9-31
© 2014 by McGraw-Hill Education. This is proprietary material solely for authorized instructor use. Not authorized for sale or distribution in
any manner. This document may not be copied, scanned, duplicated, forwarded, distributed, or posted on a website, in whole or part
Chapter 09 - Antimicrobial Chemotherapy
65. The drug of last resort that is generally used in treating infections caused by methicillin
resistant Staphylococcus aureus is
A. trimethoprim.
B. ciprofloxacin.
C. chloramphenicol.
D. vancomycin.
ASM Objective: 05.04 Microorganisms, cellular and viral, interact with both human and non-
human hosts in beneficial, neutral or detrimental ways.
ASM Topic: Module 01 Evolution
Blooms Level: 2. Understand
Learning Outcome: 09.08.02 Correlate the sensitivity of a microorganism to an antimicrobial
agent with microbial growth in the presence of that agent
Section: 09.04
Topic: Antimicrobial Medications
ASM Objective: 05.04 Microorganisms, cellular and viral, interact with both human and non-
human hosts in beneficial, neutral or detrimental ways.
ASM Topic: Module 01 Evolution
Blooms Level: 2. Understand
Learning Outcome: 09.02.01 Explain the difference between a narrow and broad spectrum
drug
Learning Outcome: 09.08.03 Identify practices that lead to antimicrobial drug resistance and
suggest countermeasures
Section: 09.08
Topic: Antimicrobial Medications
9-32
© 2014 by McGraw-Hill Education. This is proprietary material solely for authorized instructor use. Not authorized for sale or distribution in
any manner. This document may not be copied, scanned, duplicated, forwarded, distributed, or posted on a website, in whole or part
Prescott’s Microbiology Willey 9th Edition Test Bank
67. Which of the following is (are) used by microorganisms to become resistant to a particular
drug?
A. Enzymatic inactivation of the drug.
B. Exclusion of the drug from the cell.
C. An alternate metabolic pathway that bypasses the drug-sensitive step.
D. All of the choices.
ASM Objective: 05.04 Microorganisms, cellular and viral, interact with both human and non-
human hosts in beneficial, neutral or detrimental ways.
ASM Topic: Module 01 Evolution
Blooms Level: 2. Understand
Learning Outcome: 09.08.03 Identify practices that lead to antimicrobial drug resistance and
suggest countermeasures
Section: 09.08
Topic: Antimicrobial Medications
9-33
© 2014 by McGraw-Hill Education. This is proprietary material solely for authorized instructor use. Not authorized for sale or distribution in
any manner. This document may not be copied, scanned, duplicated, forwarded, distributed, or posted on a website, in whole or part